Rubella immune status of indigenous and immigrant pregnant women in Catalonia, Spain

European Journal of Public Health

Volumn 17, Issue 6, 2007, Pages 560-564

  Dominguez, Angela ^a,c,d   Plans, Pere ^a   Espuñes, Jordi ^a   Costa, Josep ^b   Torner, Nuria ^a   Cardeñosa, Neus ^a   Plasencia, Antoni ^a   Salleras, Lluís ^c  

^a Directorate of Public Health   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d Generalitat of Catalonia   (Spain)

Author keywords

Immigrant; Pregnant women; Rubella; Vaccination

Indexed keywords

RUBELLA ANTIBODY;

ADULT; ARTICLE; CONFIDENCE INTERVAL; CONGENITAL RUBELLA SYNDROME; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMIGRANT; IMMIGRATION; IMMUNE STATUS; MAJOR CLINICAL STUDY; MATERNAL CARE; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; RANDOMIZATION; RUBELLA VIRUS; SOCIAL CLASS; SPAIN; STATISTICAL SIGNIFICANCE; UMBILICAL CORD; VACCINATION;

ADULT; ANTIBODIES, VIRAL; EMIGRANTS AND IMMIGRANTS; FEMALE; FETAL BLOOD; HUMANS; POPULATION GROUPS; PREGNANCY; QUESTIONNAIRES; RUBELLA; SPAIN;

EID: 37249005871     PISSN: 11011262     EISSN: 1464360X     Source Type: Journal    
DOI: 10.1093/eurpub/ckm034     Document Type: Article

References (27)

1. Cooper L. The burden of congenital rubella syndrome. In: de Quadros CA, editor. Vaccine. Washington DC: Pan American Health Organization, 2004:53-60.
2. Spika JS, Wassilak S, Pebody R, et al. Measles and rubella in the World Health Organization European region: diversity creates challenges. J Infect Dis 2003;187:S191-7.
3. Davidkin I, Peltola H, Leinikki P. Epidemiology of rubella in Finland. Euro Surveill 2004;9:13-4.
4. Pumarola A, Salleras L, Vidal J, et al. Seroepidemiology of rubella in pregnant females in Catalonia (Spain). Rev Epidemiol Sante Publique 1987;35:136-40.
5. Tookey PA, Peckham CS. Surveillance of congenital rubella in Great Britain, 1971-96. Br Med J 1999;318:769-70.
6. Bottiger M, Forsgren M. Twenty years' experience of rubella vaccination in Sweden: 10 years of selective vaccination (of 12-year-old girls and of women postpartum) and 13 years of a general two-dose vaccination. Vaccine 1997;15:1538-44.
7. Borrás E, Domínguez A, Batalla J, Oviedo M. Coverage of vaccines included in the routine vaccination schedule in children under 3 years of age in Catalonia (Spain). Program of abstracts of the 4th World Congress of the World Society for Paediatric Infectious Diseases. 2005.
8. Schluter WW, Reef SE, Redd SC, Dykewicz CA. Changing epidemiology of congenital rubella syndrome in the United States. J Infect Dis 1998;178:636-41.
9. Danovaro-Holliday MC, LeBaron CW, Allensworth C, et al. A large rubella outbreak with spread from the workplace to the community. JAMA 2000;284:2733-9.
10. Salleras L, Plans P, Vidal J, et al. Serological evaluation of the universal hepatitis B vaccination programme of pre-adolescents in Catalonia (Spain). Vacunas 2000;1:3-6.
11. Gutiérrez N, Sanchez J, Muñoz S, et al. Seroprevalence of antibodies against Treponema pallidum, Toxoplasma gondii, rubella virus, hepatitis B and C virus, and HIV in pregnant women. Enferm Infecc Microbiol Clin 2004;22:512-6 (In Spanish).
12. Cilla G, Dorronsoro M, Saenz-Dominguez JR, et al. Increase of immunity to rubella and interruption of rubella transmission in Gipuzkoa (Basque Country, Spain) after an enhanced vaccination programme. Epidemiol Infect 2004;132:685-92.
13. Garrido E, Alvarez MJ, Gomez J, et al. Seroprevalencia of rubella antibodies in fertile immigrant women in two health centers in Madrid. Vacunas 2004;5:75-8 (In Spanish).
14. World Health Organization. Global Summary on Immunization. Available at http://www.who.int/vaccines/GlobalSummary/Immunization/ScheduleResult.cfm (22 December 2006, date accessed).
15. Pebody RG, Edmunds WJ, Conyn-van Spaendonck M, et al. The seroepidemiology of rubella in western Europe. Epidemiol Infect 2000;125:347-55.
16. Yamamoto L, Mejia E, Lopez RM, et al. Susceptibility to rubella infection in females at high risk. Immune protection associated to population density. Trop Geogr Med 1995;47:235-8.
17. Sanz JC, Lemos C, Herrera D, Ramirez-Fernandez R. [Rubella outbreak in a Latin American immigrant population]. Enferm Infecc Microbiol Clin 2004;3:197 (In Spanish).
18. Torner N, Valerio L, Costa J, et al. Rubella outbreak in young adults of Brazilian origin in a Barcelona suburb, October-December 2005. http://www.eurosurveillance.org/ew/2006/060223.asp (accessed 1 March 2006).
19. Plotkin SA, Reef SE. Rubella vaccine. In: plotkin SA, Orenstein WA, editors. Vaccines, 4th. Philadelphia: Saunders; 2004. pp. 707-43.
20. Cutts FT, Robertson SE, Diaz-Ortega JL, Samuel R. Control of rubella and congenital rubella syndrome (CRS) in developing countries, Part 1: Burden of disease from CRS. Bull World Health Organ 1997;75:55-68.
21. Gutierrez TG, Munoz O, Tapia CR, et al. [The seroepidemiology of rubella in Mexican women. A national probability survey]. Salud Publica Mex 1990;32:623-31.
22. Sheridan E, Aitken C, Jeffries D, et al. Congenital rubella syndrome: a risk in immigrant populations. Lancet 2000;359:674-5.
23. Rahi J, Adams G, Russell-Eggitt I, Tookey P. Epidemiological surveillance of rubella must continue. Br Med J 2001;323:112.
24. Departament de Sanitat i Seguretat Social. L'eliminació de la rubèola a Catalunya per l'any 2005. Barcelona: Generalitat de Catalunya; 2002.
25. Tookey PA, Cortina-Borja M, Peckham CS. Rubella susceptibility among pregnant women in North London, 1996-1999. J Public Health Med 2002;24:211-6.
26. Salleras L. Risk of congenital rubella in the children of immigrant women in Spain. Vacunas 2004;73-4 (In Spanish).
27. Bamgboye AE, Afolabi KA, Esumeh FI, Enweani IB. Prevalence of rubella antibody in pregnant women in Ibadan, Nigeria. West Afr J Med 2004;23:245-8.